Literature DB >> 9117172

Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies.

J D Cañete1, J Llena, A Collado, R Sanmartí, A Gayá, J Gratacós, M Blay, J Muñoz-Gómez.   

Abstract

Interleukin 1-beta (IL-1 beta), IL-2, IL-4, IL-5, IL-6, IL-8, tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta) and granulocyte-macrophage colony-stimulating factor (GM-CSF) gene expression was determined in knee synovium of 16 patients with rheumatoid arthritis (RA) and 16 patients with seronegative spondyloarthropathies (SSP), by using polymerase chain reaction (PCR) amplification. The pattern of cytokines observed in RA synovium is of the macrophage-fibroblast type, with the highest expression of IL-1 beta and TGF-beta. GM-CSF and IL-2 bands were visualized in a minority of patients. Neither IL-4 nor IL-5 could be detected. No significant differences were observed in the cytokine profile between patients with early (< 12 months) and more advanced disease. No differences were observed according to gender, age, rheumatoid factor status and the duration of knee synovitis. The pattern of cytokines in the synovium of SSP patients is similar to that observed in RA patients and does not change in relation to disease duration. IL-2 was the only T-cell cytokine observed. These data provide evidence that the macrophage-fibroblast cells have an important role in early and more advanced rheumatoid synovitis, and show that this is also true for SSP peripheral synovitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117172     DOI: 10.1093/rheumatology/36.1.38

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

1.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors:  A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Authors:  M D Smith; D Baeten; A-K Ulfgren; I B McInnes; O Fitzgerald; B Bresnihan; P P Tak; D Veale
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

3.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.

Authors:  J D Cañete; S E Martínez; J Farrés; R Sanmartí; M Blay; A Gómez; G Salvador; J Muñoz-Gómez
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

Review 4.  Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis.

Authors:  Gianfranco Ferraccioli; Luisa Bracci-Laudiero; Stefano Alivernini; Elisa Gremese; Barbara Tolusso; Fabrizio De Benedetti
Journal:  Mol Med       Date:  2010-08-02       Impact factor: 6.354

5.  Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids.

Authors:  I Torsteinsdóttir; N G Arvidson; R Hällgren; L Håkansson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 6.  Pathways of cell activation in spondyloarthropathies.

Authors:  U Fearon; D J Veale
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

7.  Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.

Authors:  A Calin; B A C Dijkmans; P Emery; M Hakala; J Kalden; M Leirisalo-Repo; E M Mola; C Salvarani; R Sanmartí; J Sany; J Sibilia; J Sieper; S van der Linden; E Veys; A M Appel; S Fatenejad
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

Review 8.  Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

9.  Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis.

Authors:  Ning-Sheng Lai; Jian-Liang Chou; Gary C W Chen; Su-Qin Liu; Ming-Chi Lu; Michael W Y Chan
Journal:  Mol Biol Rep       Date:  2014-02-16       Impact factor: 2.316

10.  Infliximab in the treatment of ankylosing spondylitis.

Authors:  Rebecca Grainger; Andrew A Harrison
Journal:  Biologics       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.